COVID-19
HHS Secretary Alex Azar accused of overruling FDA on COVID-19 test quality reviews
September 16, 2020Research and Development COVID-19, FDA, US, USA
Allegations have emerged accusing US Health and Human Services Secretary Alex Azar of overruling the FDA over the review of …
India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine
September 16, 2020Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine
Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …
Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study
September 16, 2020Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine
Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …
Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data
September 15, 2020Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir
Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …
AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review
September 14, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine
After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
Top Ten most popular articles on Pharmafile.com this week
September 11, 2020Medical Communications COVID-19, coronavirus, vaccines
The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness
September 9, 2020Research and Development AstraZeneca, COVID-19, pharma
Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros
September 7, 2020Sales and Marketing COVID-19, GSK, Sanofi
The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros. …
New poll indicates most Americans will not get a COVID-19 vaccine when it’s first available
September 7, 2020Sales and Marketing COVID, COVID-19, COVID-19 vaccine, coronavirus
Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …
Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients
September 4, 2020Medical Communications, Research and Development COVID-19, pharma, steroids
A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters
September 4, 2020Medical Communications COVID-19, J&J, JJ
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.
Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment
September 1, 2020Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma
Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …
Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment
August 28, 2020Medical Communications COVID-19, antibodies, coronavirus vaccine
Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …
Top Ten most popular articles on Pharmafile.com this week
August 28, 2020Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10
The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …
Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests
August 27, 2020Research and Development COVID-19
Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company.
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
